Institute for Digestive Research, Academy of Medicine, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.
Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, 24105 Kiel, Germany.
Int J Mol Sci. 2022 Feb 14;23(4):2107. doi: 10.3390/ijms23042107.
Regulatory changes occurring early in colorectal cancer development remain poorly investigated. Since the majority of cases develop from polyps in the adenoma-carcinoma transition, a search of early molecular features, such as aberrations in miRNA expression occurring prior to cancer development, would enable identification of potentially causal, rather than consequential, candidates in the progression of polyp to cancer. In the current study, by employing small RNA-seq profiling of colon biopsy samples, we described differentially expressed miRNAs and their isoforms in the adenoma-carcinoma transition. Analysis of healthy-adenoma-carcinoma sequence in an independent validation group enabled us to identify early deregulated miRNAs including hsa-miR-1246 and hsa-miR-215-5p, the expressions of which are, respectively, gradually increasing and decreasing. Loss-of-function experiments revealed that inhibition of hsa-miR-1246 lead to reduced cell viability, colony formation, and migration rate, thereby indicating an oncogenic effect of this miRNA in vitro. Subsequent western blot and luciferase reporter assay provided evidence of hsa-miR-1246 being involved in the regulation of target and genes' expression. To conclude, the present study revealed possible involvement of hsa-miR-1246 in early colorectal cancer development and regulation of tumor suppressors AXIN2 and CFTR.
结直肠癌发生早期的调控变化仍研究甚少。由于大多数病例是由腺瘤-癌过渡中的息肉发展而来,因此寻找早期分子特征,例如癌症发生前 miRNA 表达的异常,将能够识别息肉向癌症进展过程中潜在的因果候选物,而不是后果性候选物。在本研究中,我们通过对结肠活检样本的小 RNA-seq 分析,描述了在腺瘤-癌过渡中差异表达的 miRNA 及其异构体。在独立验证组中对健康-腺瘤-癌序列的分析使我们能够鉴定出早期失调的 miRNA,包括 hsa-miR-1246 和 hsa-miR-215-5p,它们的表达水平分别逐渐增加和减少。功能丧失实验表明,抑制 hsa-miR-1246 会导致细胞活力、集落形成和迁移率降低,表明该 miRNA 在体外具有致癌作用。随后的 Western blot 和荧光素酶报告基因检测提供了证据表明 hsa-miR-1246 参与了靶基因和基因的表达调控。总之,本研究揭示了 hsa-miR-1246 可能参与了结直肠癌的早期发生和肿瘤抑制基因 AXIN2 和 CFTR 的调控。